{"version":"1.0","type":"link","title":"The farnesyl transferase inhibitor darlifarnib (KO-2806) re-sensitizes relapsing tumors to RAS inhibition.","author_name":"Patel HV 외","author_url":"https://prs-insight.online/author/Patel%20HV","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97373","thumbnail_width":1200,"thumbnail_height":630}